SC&H Group White Papers: "Expertise Beyond the Numbers"
Today’s pharmaceutical executives face the daunting task of complying with the FDA’s Federal Drug Supply Chain Security Act (DSCSA), which calls for companies to track, trace, and serialize their drug products—from manufacture to distribution.
Since complying with DSCSA is requiring extensive effort, many executives are engaging an IT consultant to develop a strategy and software solution for product reporting and serialization.
In this white paper, we explore the various difficulties in complying with DSCSA, as well as how procurement professionals are helping executives to optimize their compliance efforts.
Specifically, they are guiding executives to conduct contract compliance audits during IT consultant projects and throughout the extended supply chain, thereby improving transparency, efficiency, and governance.
Download now to learn more.